Quarterly Activities/Appendix 4C Cash Flow Report

• Company announcement on 17th December that the interim research report on Anatara’s Anti- Obesity Project pre-clinical studies had concluded that a candidate compound, referred to as “AOC”, demonstrated 2 independent measures suggesting activity of statistical significance in assisting the management of weight reduction. • The completion of the Mechanism of Action (MOA) studies was delayed in De